Pantothenate Kinase-Associated Neurodegeneration (PKAN) and PLA2G6-Associated Neurodegeneration (PLAN): Review of Two Major Neurodegeneration with Brain Iron Accumulation (NBIA) Phenotypes

被引:70
|
作者
Kurian, Manju A. [1 ,2 ]
Hayflick, Susan J. [3 ,4 ,5 ]
机构
[1] UCL Inst Child Hlth, Neurosci Unit, London, England
[2] Great Ormond St Hosp Sick Children, Dept Neurol, London, England
[3] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA
[5] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
来源
基金
英国惠康基金;
关键词
INFANTILE NEUROAXONAL DYSTROPHY; HALLERVORDEN-SPATZ-SYNDROME; PALLIDAL STIMULATION; PHOSPHOLIPASE A(2); REPETITIVE SPEECH; PLA2G6; MUTATION; PANK2; MUTATIONS; TIGER SIGN; DYSTONIA; SPECTRUM;
D O I
10.1016/B978-0-12-410502-7.00003-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurodegeneration with brain iron accumulation (NBIA) comprises a heterogeneous group of disorders characterized by the presence of radiologically discernible high brain iron, particularly within the basal ganglia. A number of childhood NBIA syndromes are described, of which two of the major subtypes are pantothenate kinase-associated neurodegeneration (PKAN) and PLA2G6-associated neurodegeneration (PLAN). PKAN and PLAN are autosomal recessive NBIA disorders due to mutations in PANK2 and PLA2G6, respectively. Presentation is usually in childhood, with features of neurological regression and motor dysfunction. In both PKAN and PLAN, a number of classical and atypical phenotypes are reported. In this chapter, we describe the clinical, radiological, and genetic features of these two disorders and also discuss the pathophysiological mechanisms postulated to play a role in disease pathogenesis.
引用
收藏
页码:49 / 71
页数:23
相关论文
共 50 条
  • [1] PLA2G6-Associated Neurodegeneration (PLAN): Review of Clinical Phenotypes and Genotypes
    Guo, Yu-pei
    Tang, Bei-sha
    Guo, Ji-feng
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [2] Clinical heterogeneity of pantothenate kinase-associated neurodegeneration (PKAN)
    Thomas, M
    Hayflick, SJ
    Jankovic, J
    NEUROLOGY, 2002, 58 (07) : A322 - A322
  • [3] PLA2G6-Associated Neurodegeneration: A Rare Case Report of Neurodegeneration with Brain Iron Accumulation in Children
    Widianti, Nurani
    Hanindita, Meta Herdiana
    Widjaja, Nur Aisiyah
    Irawan, Roedi
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2023, 39 (01)
  • [4] Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up
    Cossu, Giovanni
    Abbruzzese, Giovanni
    Matta, Gildo
    Murgia, Daniela
    Melis, Maurizio
    Ricchi, Valeria
    Galanello, Renzo
    Barella, Susanna
    Origa, Raffaella
    Balocco, Manuela
    Pelosin, Elisa
    Marchese, Roberta
    Ruffinengo, Uberto
    Forni, Gian Luca
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (06) : 651 - 654
  • [5] Diagnosis and Treatment of Pantothenate Kinase-Associated Neurodegeneration (PKAN): A Systematic Review
    Pohane, Meera R.
    Dafre, Rajshri
    Sontakke, Nikhil G.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [6] PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes
    Shah-Zamora, D.
    Bailey, M.
    MOVEMENT DISORDERS, 2021, 36 : S513 - S513
  • [7] Pantothenate kinase-associated neurodegeneration (PKAN) - a rare clinical entity
    Saha, Appas
    Shabnam, Srushti
    Swapna, N.
    ACTA OTO-LARYNGOLOGICA CASE REPORTS, 2016, 1 (01): : 90 - 97
  • [8] Patient and Caregiver Experience With Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Escolar, M.
    Lenderking, W.
    Collins, A.
    Jinnah, K.
    Klopstock, T.
    Kruer, M.
    Videnovic, A.
    Robichaux-Viehoever, A.
    Swett, L.
    Revicki, D.
    Bender, R.
    Marshall, R.
    ANNALS OF NEUROLOGY, 2018, 84 : S369 - S369
  • [9] A randomized trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration (PKAN)
    Klopstock, T.
    Tricta, F.
    Fradette, C.
    Spino, M.
    Buechner, B.
    Karin, I.
    Neumayr, L.
    Aguilar, C.
    Zhao, F.
    Kmiec, T.
    Nardocci, N.
    Zorzi, G.
    Steele, H.
    Horvath, R.
    Chinnery, P.
    Hogarth, P.
    Hayflick, S. J.
    Blamire, A.
    Vichinsky, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 34 - 34
  • [10] Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration
    Thomas, M
    Hayflick, SJ
    Jankovic, J
    MOVEMENT DISORDERS, 2004, 19 (01) : 36 - 42